ImmuCell Corporation

ICCC Healthcare Biotechnology

ImmuCell Corporation’s revenue for fiscal 2025 (year ended December 2025) was $27.6 million, up 4.34% from fiscal 2024. In the quarter to June 2026, revenue grew 11.5%, EPS grew 233.3%, free cash flow grew 54.9% and total debt fell 15.3%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

10.75 0.19 +1.80%
Market cap
$95.9M
P/E
126×
Fwd P/E
−779×
Dividend yield
—
F-score
7/9
Altman Z
2.80
Beneish M
−3.10
Dividend safety
n/a
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
43.18 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Piotroski F-Score
2 2 2 7 5 7 1 1 7 7
Altman Z-Score
4.20 2.95 2.39 2.68 2.57 3.77 2.30 1.04 1.75 2.80
P/S ratio
2.63 3.92 3.52 2.56 2.80 3.16 2.70 2.22 1.59 2.01
P/FCF ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 44.02
Altman Z″-Score (non-manufacturers)
7.82 3.40 2.42 4.56 3.55 4.67 3.00 0.71 1.92 2.93
Beneish M-Score
(2.14) (2.31) (3.31) (2.13) (0.67) (2.20) (2.61) (1.58) (2.23) (3.10)
P/Operating CF
(67.59) 123.76 (279.67) (753.60) 274.58 103.31 (38.67) (53.58) (13,568.09) 115.05
P/B ratio
1.28 1.73 1.78 1.21 1.52 1.86 1.65 1.55 1.53 2.05
EV/Sales
1.84 4.42 4.18 2.53 2.90 3.10 2.94 2.85 1.84 2.20
EV/EBITDA
10.36 69.66 504.64 26.13 41.57 21.89 278.42 0.00 44.82 13.72
EV/FCF
(4.64) (2.79) (21.33) (49.11) (16.40) (36.41) (9.92) (7.58) (472.81) 48.22
Current Ratio
6.97 3.64 2.50 5.29 5.50 6.42 4.56 2.73 3.41 4.26
Net Debt/EBITDA
(4.50) 7.79 79.61 (0.26) 1.45 (0.38) 22.61 (3.65) 6.22 1.19
Debt/Equity
0.15 0.38 0.45 0.29 0.34 0.28 0.34 0.48 0.38 0.34
ROE
3.35% (0.78%) (10.24%) (5.11%) (3.57%) (0.26%) (7.92%) (20.86%) (8.21%) (3.81%)
ROA
2.59% (0.57%) (6.93%) (3.63%) (2.59%) (0.18%) (5.58%) (13.03%) (4.85%) (2.37%)
ROIC
4.59% (0.53%) (3.12%) (2.08%) (2.89%) 0.51% (4.13%) (9.98%) (2.99%) 3.19%
Return on Tangible Assets
2.30% (0.53%) (7.77%) (3.60%) (2.78%) (0.19%) (6.34%) (16.57%) (5.99%) (3.06%)
Average Days of Receivables
37.95 47.03 30.97 43.55 42.75 51.10 34.57 45.66 51.95 45.14
Earnings Yield
2.32% (0.48%) (6.10%) (3.69%) (2.35%) (0.13%) (5.00%) (15.00%) (5.63%) (1.71%)
Free Cash Flow Yield
(15.02%) (40.41%) (5.57%) (2.02%) (6.32%) (2.70%) (10.98%) (16.94%) (0.25%) 2.27%
Free Cash Flow per Share
(0.89) (3.34) (0.39) (0.10) (0.38) (0.22) (0.71) (0.85) (0.01) 0.14
Book value per Share
4.67 4.77 3.96 4.25 3.92 4.29 3.92 3.23 3.37 3.00
Free Cash Flow
(3.78) (16.54) (2.15) (0.71) (2.71) (1.64) (5.51) (6.56) (0.10) 1.26
EV/EBIT
19.69 0.00 0.00 0.00 0.00 231.90 0.00 0.00 0.00 36.87
Other line items

Show all line items

Columns are period end dates